Sanjay Subramanian - 21 Mar 2022 Form 3 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
SVP, CFO
Signature
/s/ Sanjay Subramanian
Issuer symbol
INZY
Transactions as of
21 Mar 2022
Net transactions value
$0
Form type
3
Filing time
22 Mar 2022, 16:08:50 UTC
Previous filing
05 Jan 2022
Next filing
20 Apr 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit Index: 24.1 Power of Attorney